- China Is the Contrarian Trade of 2024 (bloomberg)
- Boeing Slides Further as More Loose Parts Found (barrons)
- Intel Holds an AI PC Pep Rally at CES Convention (barrons)
- Healthcare Stocks Are Trying to Break Out. What They Need Now. (barrons)
- Amazon and 2 More Stocks Are Winners as Ad Growth Ramps Up This Year, Analyst Says (barrons)
- Comcast Stock and 5 Other Losers That Look Ready to Become Winners (barrons)
- Biotech Is Ripe for M&A. These May Be the Next Acquisition Targets. (barrons)
- Activist investor Elliott takes big stake in Match Group, seeks changes: report (marketwatch)
- GSK to buy asthma-drug developer for up to $1.4 billion in pipeline push (marketwatch)
- Volkswagen sales rose 12% in 2023, hitting target despite China issues (marketwatch)
- Here are Wall Street’s favorite stocks in the sector expected to grow profits the most in 2024 (marketwatch)
- Offices Around America Hit a New Vacancy Record (wsj)
- Novartis in Advanced Talks to Buy Cytokinetics (wsj)
- America Has Plenty of Natural Gas. So Why Is New England Left Out in the Cold? (wsj)
- ‘Market’s Wrong, I’m Not’: Mike Mayo Loves Playing a Provocateur (bloomberg)
- The S&P 500 might leap 10% to a record high this year – but plunging interest rates could spell trouble for stocks, Wharton professor Jeremy Siegel says (businessinsider)
- China to persist with AI development efforts in 2024, despite US chip curbs: UBS (scmp)
- Alibaba’s DingTalk updates workplace collaboration app with new AI agent (scmp)
- Cainiao offers shoppers in US grouped delivery service, cutting shipping times (scmp)
- Russell 2000 (RUT) outlook for 2024, as per Goldman Sachs (streetinsider)